Skip to content

The study of postoperative residual neuromuscular blockade antagonism in patients after general anesthesia

The study of postoperative residual neuromuscular blockade antagonism in patients after general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007803
Enrollment
Unknown
Registered
2016-01-17
Start date
2016-01-19
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing laparoscopic cholecystectomy surgery

Interventions

neostigmine group:intravenous injection of neostigmine and atropine
placebo group:intravenous injection of normal saline

Sponsors

The second affiliated hospital of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients scheduled for laparoscopic cholecystectomy surgery under general anesthesia; intraoperative use muscle relaxants; aged more than 18 years old, with American Society of Anesthesiologists grading I-III.

Exclusion criteria

Exclusion criteria: Cardiopulmonary dysfunction, acute anterior surgery pulmonary disease, chest or abdominal surgery, multiple trauma, abnormal liver function, renal insufficiency or renal failure, the potential of neuromuscular disease, preoperative use of drugs interfere with neuromuscular transmission, contraindication for neostigmine and atropine, surgical position hinder judgment by the ulnar nerve monitoring the degree of muscle relaxation, intraoperative hypothermia (T 35kg/m2).

Design outcomes

Primary

MeasureTime frame
incidence of postoperative nausea and vomiting;incidence of arrhythmia;incidence of oxygen desaturation after extubation;

Secondary

MeasureTime frame
the incidence of RNMB;length of PACU stay time.;Pulmonary complications within 7 postoperative days;

Countries

China

Contacts

Public ContactMin Yan
yanminnina@hotmail.com+86 13757118632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026